Treatment Outcomes and Overall Survival of Patients With B‐Cell Prolymphocytic Leukemia

ABSTRACT Introduction B‐cell prolymphocytic leukemia (B‐PLL) is a rare, aggressive leukemic B‐cell malignancy historically associated with poor outcomes and recently reclassified in the WHO Fifth Edition but retained as a distinct entity in the ICC. Methods We analyzed 950 patients labeled as B‐PLL...

Descrición completa

Detalles Bibliográficos

Principais autores:	Daniel A. Ermann, Victoria A. Vardell, Lindsey Fitzgerald, Allison Bock, Harsh Shah, Boyu Hu, Deborah M. Stephens
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wiley 2026-06-01
Series:	eJHaem
Assuntos:	B‐cell prolymphocytic leukemia B‐PLL incidence survival treatment outcomes lymphoid leukemia
Acceso en liña:	https://doi.org/10.1002/jha2.70299
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!